Week 12: The First Big Milestone
Three full months on semaglutide. Twelve injections, two dose steps, and a body that has learned what this medication feels like. Week 12 is the standard checkpoint — a place to take stock, review with your prescriber, and decide what the next phase looks like.
Week 12 is the last week of the 1.0mg block under the standard Wegovy schedule. If you and your prescriber agree, week 13 will bring the next titration to 1.7mg. If you would rather hold at 1.0mg longer — for tolerability, life logistics, or simply because the dose is working — that is a legitimate path many people take.
Across clinical trials, the average semaglutide user has lost meaningful weight by the 12-week mark — STEP trial data shows cumulative loss in the range of roughly 6% of starting body weight by this point on the titration schedule, with wide individual variation. Your number may be higher, lower, or different depending on starting weight, baseline diet, and how the titration cadence has gone for you. The trend matters more than the absolute number.
Appetite Suppression
Reliable, often profound suppression by the end of the 1.0mg phase. The next titration tends to deepen it further, with diminishing returns at higher doses for some.
Mean cumulative loss by week 12 in STEP trial cohorts on the titration schedule was around 6% of starting weight, with wide individual variation.
Week 12 Timeline
The Week 12 Timeline
Day 78 (Injection 12)
Final 1.0mg Dose
If you titrate next week, this is your last 1.0mg injection. If you hold, another four-week cycle begins at the same dose.
Days 80-82
Three-Month Review
Pull weight, measurements, side effect notes, and habit shifts together. Most prescribers do a formal check at this point — bring data, not just impressions.
Day 84
Decision Point
Titrate to 1.7mg, hold at 1.0mg, or — rarely — step back. All are valid, depending on response and tolerability. Confirm the plan before your next pen.
Navigating Symptoms
Constipation, mild reflux, and occasional fatigue are the most common lingering effects at the end of the 1.0mg phase. None are typically severe at this stage.
What to focus on at this milestone: the trend, the habits, and the next step. The trend should be a generally downward weight line over 12 weeks, even if individual weeks were flat. The habits should feel less effortful than they did in month one. The next step is whatever your prescriber and you agree on, informed by how the previous two dose changes felt.
It is also worth acknowledging the work. Twelve weeks of injections, side effect navigation, food experimentation, and pattern building is a real investment. The 1.0mg phase is often the first time people describe semaglutide as feeling sustainable rather than novel — that shift is part of why the medication tends to work over the long term.
What Users Report
“Three months in, I'm down a meaningful amount, but the bigger thing is that I trust the process now. I'm not white-knuckling it. The medication does its part and I do mine.”
— Lila S.
“My doctor and I agreed to hold at 1.0mg another month before going to 1.7mg. The pace felt right and there was no reason to rush.”
— Anthony R.
Looking ahead
Beyond week 12, the journey shifts from titration to longer-term work — maintaining habits, navigating plateaus, and deciding whether and when to step up to higher doses. Visit the resources hub for guides on the months ahead, or revisit the earlier weeks if you want to see how far you have come.